Your browser doesn't support javascript.
loading
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Dougan, Michael; Azizad, Masoud; Mocherla, Bharat; Gottlieb, Robert L; Chen, Peter; Hebert, Corey; Perry, Russell; Boscia, Joseph; Heller, Barry; Morris, Jason; Crystal, Chad; Igbinadolor, Awawu; Huhn, Gregory; Cardona, Jose; Shawa, Imad; Kumar, Princy; Blomkalns, Andra; Adams, Andrew C; Van Naarden, Jacob; Custer, Kenneth L; Knorr, Jack; Oakley, Gerard; Schade, Andrew E; Holzer, Timothy R; Ebert, Philip J; Higgs, Richard E; Sabo, Janelle; Patel, Dipak R; Dabora, Matan C; Williams, Mark; Klekotka, Paul; Shen, Lei; Skovronsky, Daniel M; Nirula, Ajay.
Afiliação
  • Dougan M; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Azizad M; Valley Clinical Trials Northridge, Northridge, California, USA.
  • Mocherla B; Las Vegas Medical Research Center, Las Vegas, Nevada, USA.
  • Gottlieb RL; Baylor University Medical Center, Dallas, Texas, USA.
  • Chen P; Baylor Scott and White Research Institute, Dallas, Texas, USA.
  • Hebert C; Department of Medicine, Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Perry R; NOLA Research Works, New Orleans, Louisiana, USA.
  • Boscia J; Gadolin Research, Beaumont, Texas, USA.
  • Heller B; Vitalink Research, Union, South Carolina, USA.
  • Morris J; Long Beach Clinical Trials, Long Beach, California, USA.
  • Crystal C; Care Access, Lake Charles, California, USA.
  • Igbinadolor A; Eastside Research Associates, Redmond, Washington, USA.
  • Huhn G; Monroe Biomedical Research, Monroe, North Carolina, USA.
  • Cardona J; Cook County Health, Chicago, Illinois, USA.
  • Shawa I; Indago Research and Health Center, Hialeah, Florida, USA.
  • Kumar P; Franciscan Health Indianapolis Hospital, Indianapolis, Indiana, USA.
  • Blomkalns A; Georgetown University Medical Center, Washington D.C., USA.
  • Adams AC; Stanford University School of Medicine, Palo Alto, California, USAand.
  • Van Naarden J; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Custer KL; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Knorr J; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Oakley G; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Schade AE; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Holzer TR; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Ebert PJ; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Higgs RE; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Sabo J; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Patel DR; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Dabora MC; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Williams M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Klekotka P; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Shen L; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Skovronsky DM; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Nirula A; Eli Lilly and Company, Indianapolis, Indiana, USA.
Clin Infect Dis ; 75(1): e440-e449, 2022 08 24.
Article em En | MEDLINE | ID: mdl-34718468
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article